Seven Years Running Praised as benchmark for small and medium-sized enterprises SOUTH SAN FRANCISCO, CA and TAIPEI, Taiwan - May 3, 2021 - TLC(Nasdaq: TLC, TWO: 4152), a clinical-stagespecialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that it once again ranks in the Top 5% in Corporate Governance Evaluation amongst all Taiwan Stock Exchange Corporation (TWSE) and Taipei Exchange (TPEx) listed companies. This marks the seventh consecutive year TLC has won the prestigious status since the establishment of the evaluation system in 2015, and TLC remains the only biotech company to have gained such an honor. In addition, TLC also ranks in the Top 5% in the newly added, non-industry-specific,Small and Medium-SizedEnterprises (SMEs) category (TWD 5-10billion market value) with 5 other TPEx-listedcompanies.
January 20, 2021
A call for “ready to change” was made among over 300 senior executives and high-level officials at Cathay Sustainable Finance and Climate Change Summit 2020 in Taipei on December 10, 2020. Photo courtesy of José Miguel Salazar
Sustainable investing strategies have ascended quickly in the last 10 years. The events of this year have been first and foremost a human tragedy, but they also have served as a catalyst to awakening interest and adoption of these strategies as reasonable approaches to remain resilient during these uncertain times. Indeed, in early 2020, J.P. Morgan Global Equity Research estimated that the sustainable investing market is expected to reach $45 trillion in assets under management (AUM) by the end of the year.